Abstract: The present disclosure relates to a medication for treating a lung injury. Specifically, the present disclosure provides a use of an annexin in preparation of a composition or a formulation. The composition or formulation has one or more uses selected from the following group consisting of: (i) preventing and/or treating a lung injury; and (ii) reducing neutrophil aggregation.

Abstract: A cell-free fat extract has a therapeutic applications. The cell-free fat extract is used for preparing a composition or preparation, and the composition or preparation is for one or more uses selected from the group consisting of: (i) prevention and/or treatment of arthritis; (ii) prevention and/or treatment of pain; and (iii) movement disorder.

Abstract: The present invention relates to the therapeutic use of a cell-free fat extract solution for pulmonary diseases. In particular, provided in the present invention is the use of a cell-free fat extract in the preparation of a composition or a preparation. The composition for preparation is used for preventing and/or treating pulmonary fibrosis. The cell-free fat extract solution of the present invention has an excellent therapeutic effect on pulmonary fibrosis.

Abstract: Disclosed are a cell-free fat extract and a preparation method therefor and the method of use thereof. The cell-free fat extract is used for preparing a composition or a preparation, wherein the composition or preparation is used in a method of: preventing and/or treating acute respiratory distress syndrome and/or acute lung injury, preventing and/or treating hypoxemia, improving pulmonary tissue inflammations, improving pulmonary tissue injuries, preventing and/or treating systemic inflammatory response syndrome, and preventing and/or treating multiple organ failure.